Location
United States, North America
Cheque size
$500K - $15M
Investment Stage
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
BioTech
Pharmaceuticals
About Investor
Diego Miralles is President and Head of Research and Development at Artiva Biotherapeutics, where he leads clinical and therapeutic development in autoimmune diseases. He is also listed as a Venture Partner at Cardinal Partners and previously served as CEO-Partner at Flagship Pioneering, leading Laronde. His background includes CEO roles at Vividion Therapeutics and senior leadership at Johnson & Johnson Innovation. He specializes in biotechnology, pharmaceutical development, and life sciences company building.
Previous investments
Laronde
440M |2021
50M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
